Medicus Pharma Warrant
MDCXW
6 hedge funds and large institutions have $120K invested in Medicus Pharma Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0.15% more ownership
Funds ownership: 17.53% → 17.68% (+0.15%)
28% less capital invested
Capital invested by funds: $167K → $120K (-$46.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
Top Sellers
MDCXW Hedge Fund Activity: Q1 2026 in Review
6 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q1 2026, worth a combined $120K — down 28% from $167K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MDCXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.2K.
- 6 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q1 2026, up from 5 in Q4 2025.
- Funds reported $120K of Medicus Pharma Warrant stock for Q1 2026, down 28% quarter-over-quarter.
- 1 fund opened new Medicus Pharma Warrant positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest Medicus Pharma Warrant buyer in Q1 2026 was UBS Group, an estimated $1.2K added.
Based on aggregated 13F filings for Q1 2026.